-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Lqx6ehXyVO5I5UG+1Xfa2keJEICpYjZmjdPkDyM0w8zUOx9aFCEKntIljwAEyDrR ZWcQNEhSUEiclJnT1IsydQ== 0000000000-07-059136.txt : 20080122 0000000000-07-059136.hdr.sgml : 20080121 20071206090805 ACCESSION NUMBER: 0000000000-07-059136 CONFORMED SUBMISSION TYPE: UPLOAD PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20071206 FILED FOR: COMPANY DATA: COMPANY CONFORMED NAME: GENAERA CORP CENTRAL INDEX KEY: 0000880431 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 133445668 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: UPLOAD BUSINESS ADDRESS: STREET 1: 5110 CAMPUS DR CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 BUSINESS PHONE: 6109415231 MAIL ADDRESS: STREET 1: 5110 CAMPUS DRIVE CITY: PLYMOUTH MEETING STATE: PA ZIP: 19462 FORMER COMPANY: FORMER CONFORMED NAME: MAGAININ PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 PUBLIC REFERENCE ACCESSION NUMBER: 0001193125-07-054619 LETTER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C0-)>+CS],-"C8@,"!O8FH@/#PO3&EN96%R:7IE9"`Q+TP@-S,X M-2]/(#@O12`S,C(R+TX@,2]4(#7!E+U!A9V4^/@UE;F1O8FH-.2`P(&]B:CP\+T9O;G0\/"]45#(@,3`@,"!2 M+U14-"`Q,B`P(%(^/B]07!E+T9O;G0^ M/@UE;F1O8FH-,3$@,"!O8FH\/"],96YG=&@@-SI MV@V\$*#:I&D@8L?X[IY[[KD[OYLQ6%:CZV1TGB0N,$@6 M(^:"@U]<8@=")Z)Q`,EZY,`2?TFJ'F\C"TCR$[-0QW%" M%<=NMV^C%^M9.0R`_(]N=?V/41]/JN+#00. M<^!T*-:'8B84_.?/6*1B34(:6S]$"<$9N"K+$_A/`W8[P"PR:584/@J>YP(> M*3R(+-L-#*+.P#4)SD0NBQ*>92I@6HI*SD5.?!I9-7*J-W/H\!A#SUC>K*18 MD`N\`1.9\SR5/(-/YL0\)4%%>%:*F?4I#6$;&-:=R+DH.=P4Y:8H>2V+_`^% M\1E6\883.Z#,,@QNB.WALJU@7,I7T85\L:;9SEPIMO4*'HGMT]`2HI;Y\@RF M5\!B+W#?91V[P3/=8"0>*(EK++ZZR:CKQ;Y!]5E<0IL+8:[O6'L9D0"CFBA[ MO7)(2*-Q(+8;^@[*>U*4:V"._0`++%2]$DAWE2+7WP0OX3:?B[F1D5+0!=,2 M"H8E,_P-=&W<6Q-LGCDV39FN@'GORF]H`$\%!?1ELSCPF;G>CPR3V\7>(#C, M]KBCQRH5I5VM6*+*<]FZ;;@/J!?Z.(J4D^,"-;%M<^MX$!VJ*!ZR'%E?!:PX MBB8MUIM,U$A*L2VA%*]2O$&Q@)UZU9`8#D'6(CFEYA==,H)]@553`HVL!SV@ M=("\@,6VQ#*6*I:Z)O*Z,J[MQO>`+M;3Q1JZ>(TZT'*2%=0X!F/4B2!*+?2D MC%L:7!IJS?:#;4:0`)0P-JL;>B%BS8DN=*K>(WP7[:;4&_WNJ_;.6HN=L3@S MRQ#`WXSY8U3WRG6,J`KCL\/0Q03SQ[2%SP]0_NH--=CF>&\HM+&NU!477709 M=YLF^M8L#3%U"^&0L66;/RZ^=:W=MG$[>(?LKO:,<%H8H^:P"]!EL=";)@L< MQ+U0>J[M_?,#LF^3T6\!!@`+QL;="@T*96YD7!E+T9O;G1$97-C2A4 M:6UE7!E+U!A9V5S+TMI9'-;."`P(%)=/CX-96YD;V)J#30@ M,"!O8FH\/"]3=6)T>7!E+UA-3"],96YG=&@@,S4V,2]4>7!E+TUE=&%D871A M/CYS=')E86T-"CP_>'!A8VME="!B96=I;CTB[[N_(B!I9#TB5S5-,$UP0V5H M:4AZDY48WIK8SED(C\^"CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z M;G,Z;65T82\B('@Z>&UP=&L](C,N,2TW,#$B/@H@("`\&%P.D-R96%T;W)4;V]L/@H@("`@("`@("`\>&%P.DUO9&EF>41A=&4^,C`P M-RTQ,BTP-E0P.3HP-SHS."TP-3HP,#PO>&%P.DUO9&EF>41A=&4^"B`@("`@ M(#PO&%P34TZ26YS=&%N8V5)1#YU=6ED M.F1A-CAC-CEF+3@V9#&%P34TZ M26YS=&%N8V5)1#X*("`@("`@/"]R9&8Z1&5S8W)I<'1I;VX^"B`@(#PO')E9@T*,"`V#0HP,#`P,#`P,#`P(#8U-3,U(&8-"C`P,#`P M,#,R,C(@,#`P,#`@;@T*,#`P,#`P,S(U-2`P,#`P,"!N#0HP,#`P,#`S,C -----END PRIVACY-ENHANCED MESSAGE-----